A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: Results of a multicenter placebo-controlled study

Journal of the American Academy of Dermatology

Volumn 31, Issue 1, 1994, Pages 68-74

  Pamphile, R ^a   Dubertret, L ^a  

^a NONE

^b ICL Hygee   (France)

^c NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CYCLOSPORIN; NEW DRUG; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TOPICAL DRUG ADMINISTRATION;

EID: 0028237398     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(94)70138-5     Document Type: Article

References (23)

1. A novel approach for the evaluation and treatment of psoriasis
2. An open study of vitamin D3 treatment in psoriasis vulgaris
3. Topically applied and orally administered 1,25-dihydroxyvitamin D3 is a novel safe and effective therapy for the treatment of psoriasis: a three years experience with histologic analysis [Abstract]
4. 3 (calcitriol) ointment in psoriasis
5. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells
6. Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo
7. 3 analogue stimulates differentiation and inhibits proliferation of cultured human keratinocytes [Abstract]
8. 3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro
9. Expression of in-terleukin-6—like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC 903)
10. Treatment of psoriasis by the topical application of the novel vitamin D3 analogue MC903
11. Double blind right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
12. Efficacy and safety of calcipotriol (MC903) ointment in psoriasis vulgaris
13. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris
14. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis
15. Potentiation of immunosuppressive effects of cyclosporine A by 1 alpha,25-dihydroxyvitamin D3
16. l,25-Dihydroxyvitamin D3 potentiates the in vitro inhibitory effects of cyclosporine A on T cells from rheumatoid arthritis patients
17. In vivo beneficial effects of cyclosporine A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis
18. Calcipotriol potentiates the immunosuppressive effects of cyclosporine A in allogeneic reactions [Abstract]
19. Enhancement of skin allograft survival in mice by association of 1-alpha hydroxyvitamin D3 to infratherapeutic doses of cyclosporine A
20. Immunological properties of 1,25 vitamin D3 analogues: a strong effect on the prolongation of mouse skin allograft survival
21. Reproducibility of clinical trials of topical glucocorticosteroids
22. Efficacy of low dose cyclosporine A in psoriasis: results of dose-finding studies
23. Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis